Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Exosomes and Microvesicles

Yong Zeng's Biography



Yong Zeng, Associate Professor, University of Florida

Dr. Zeng is an associate professor of chemistry and affiliate faculty of Biomedical Engineering at the University of Florida, and a member of UF Health Cancer Center. He obtained his PhD in Chemistry from University of Alberta, Canada and completed the postdoc training at University of California, Berkeley. Dr. Zeng’s research draws on chemistry, nanomaterials, bioengineering, and medicine to develop innovative micro and nanoscale tools to advance precision medicine of cancer. His technology innovations span from biomolecular assays to micro/nano systems for sensitive measurements of liquid biopsies and molecular biomarkers. His group is also devoted to translational research to bring the technological innovations to clinical sciences, closely collaborating with biologists and clinicians. Dr. Zeng is internationally recognized for his pioneering research in developing microfluidic technologies for isolation and analysis of tumor-derived extracellular vesicles (EVs) for cancer diagnostics and therapeutics. His research programs have been continuously funded by NIH and other funding agencies and led to many highly visible publications on top-tier journals, including Nat. Biomed. Eng. and Sci. Transl. Med., which were featured in public media outlets such as the NIH Director’s Blog and the JAMA Network.

Yong Zeng Image

Microfluidic Technology for Analysis of Plasma-Derived Exosomes

Tuesday, 24 March 2015 at 09:00

Add to Calendar ▼2015-03-24 09:00:002015-03-24 10:00:00Europe/LondonMicrofluidic Technology for Analysis of Plasma-Derived ExosomesSELECTBIOenquiries@selectbiosciences.com

This presentation will discuss an integrated microfluidic system that streamlines and expedites immuno-isolation, surface phenotyping, and intravesicular protein analysis of tumor-derived circulating exosomes from cancer patients.  Microfluidics has evolved from initially a scale-dependent chemical analysis technology towards a versatile platform for quantitative analysis of molecular and cellular events in complex biological systems. We have developed microfluidics-based biotechnologies and assays for quantitative measurement of circulating cancer biomarkers, such as glycoproteins and exosomes. This presentation will discuss an integrated microfluidic system that streamlines and expedites immuno-isolation, surface phenotyping, and intravesicular protein analysis of tumor-derived circulating exosomes from cancer patients.


Add to Calendar ▼2015-03-23 00:00:002015-03-24 00:00:00Europe/LondonExosomes and MicrovesiclesSELECTBIOenquiries@selectbiosciences.com